ArticleFrontiers in bioengineering and biotechnology2026
Preclinical model of Echinacea-functionalized silk fibroin-chitosan transparent membranes with enhanced hair follicle regeneration and antibacterial properties for wound healing.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Skin serves as a crucial barrier that separates the human body from the external environment. Its complex structure can make it susceptible to microbial infection and bleeding, leading to poor wound healing. Therefore, it is of important clinical significance to develop a wound dressing that can form scarless tissues with hair follicles, inhibit bacterial infection, and promote hemostasis. Methods: In this study, we constructed composite dressings based on Echinacea-loaded silk fibroin/chitosan (ESC) that had excellent mechanical properties and air permeability for the promotion of hair follicle regeneration and scarless wound healing. Additionally, the transparency of ESC facilitated observation of the wound healing process. Results: ESC exhibits superior biocompatibility that effectively alleviates inflammatory reactions in wounds. In vitro assays showed that ESC has excellent tissue adhesion and hemostatic abilities. In vivo wound healing assays comparing SF-CS and commercial Tegaderm™ Film groups showed that ESC could accelerate wound angiogenesis, collagen deposition, keratinocyte proliferation, macrophage M1-M2 transition, and inhibit inflammation, indicating effective promotion of scarless skin regeneration. Discussion: These transparent dressings based on natural materials show great potential for scarless skin regeneration and treating acute injury hemostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.